| DESCRIPTION | - AASLAND et al., Br. J. Cancer, (19880000), vol. 57, pages 358 - 363 | - |
| DESCRIPTION | - AGNEW, Chern Intl. Ed. Engl., (19940000), vol. 33, pages 183 - 186 | - |
| DESCRIPTION | - AGUS et al., Cancer Cell, (20020000), vol. 2, pages 127 - 137 | - |
| DESCRIPTION | - AGUS et al., Proc Am Soc Clin Oncol, (20030000), vol. 22, page 192 | - |
| DESCRIPTION | - A. L. LEHNINGER, Biochemistry, Worth Publishers, (19750000), pages 73 - 75 | - |
| DESCRIPTION | - ARTEAGA et al., Cancer Res., (19940000), vol. 54, pages 3758 - 3765 | - |
| DESCRIPTION | - BACUS et al., Cancer Research, (19920000), vol. 52, pages 2580 - 2589 | - |
| DESCRIPTION | - BACUS et al., Molecular Carcinogenesis, (19900000), vol. 3, pages 350 - 362 | - |
| DESCRIPTION | - BASELGA et al., J. Clin. Oncol., (19960000), vol. 14, pages 737 - 744 | - |
| DESCRIPTION | - BASELGA; MENDELSOHN, Pharmac. Ther., (19940000), vol. 64, pages 127 - 154 | - |
| DESCRIPTION | - BORST et al., Gynecol. Oncol., (19900000), vol. 38, page 364 | - |
| DESCRIPTION | - BRENNAN et al., Science, (19850000), vol. 229, page 81 | - |
| DESCRIPTION | - BRODEUR et al., Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., (19870000), pages 51 - 63 | - |
| DESCRIPTION | - BRUGGERMANN et al., Year in Immuno., (19930000), vol. 7, page 33 | - |
| DESCRIPTION | - CAPEL et al., Immunomethods, (19940000), vol. 4, pages 25 - 34 | - |
| DESCRIPTION | - CARON et al., J. Exp Med., (19920000), vol. 176, pages 1191 - 1195 | - |
| DESCRIPTION | - CARPENTER et al., Ann. Rev. Biochem., (19870000), vol. 56, pages 881 - 914 | - |
| DESCRIPTION | - CARRAWAY; CANTLEY, Cell, (19940000), vol. 78, pages 5 - 8 | - |
| DESCRIPTION | - CARRAWAY et al., Nature, (19970000), vol. 387, pages 512 - 516 | - |
| DESCRIPTION | - CARTER et al., Bio/Technology, (19920000), vol. 10, pages 163 - 167 | - |
| DESCRIPTION | - CARTER et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, page 4285 | - |
| DESCRIPTION | - CHANG et al., Nature, (19970000), vol. 387, pages 509 - 512 | - |
| DESCRIPTION | - CHARI et al., Cancer Research, (19920000), vol. 52, pages 127 - 131 | - |
| DESCRIPTION | - CHO et al., Nature, (20030000), vol. 421, pages 756 - 760 | - |
| DESCRIPTION | - CHOTHIA et al., J. Mol. Biol., (19870000), vol. 196, page 901 | - |
| DESCRIPTION | - CHOTHIA; LESK, J. Mol. Biol., (19870000), vol. 196, pages 901 - 917 | - |
| DESCRIPTION | - CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628 | - |
| DESCRIPTION | - CLYNES et al., PNAS (USA), (19980000), vol. 95, pages 652 - 656 | - |
| DESCRIPTION | - COHEN et al., Oncogene, (19890000), vol. 4, pages 81 - 88 | - |
| DESCRIPTION | - COOK et al., Mol. Cell. Biol., (19910000), vol. 11, pages 2547 - 2557 | - |
| DESCRIPTION | - CUNNINGHAM; WELLS, Science, (19890000), vol. 244, pages 1081 - 1085 | - |
| DESCRIPTION | - DAERON, Annu. Rev. Immunol., (19970000), vol. 15, pages 203 - 234 | - |
| DESCRIPTION | - DE HAAS et al., J. Lab. Clin. Med., (19950000), vol. 126, pages 330 - 41 | - |
| DESCRIPTION | - DREBIN et al., Cell, (19850000), vol. 41, pages 695 - 706 | - |
| DESCRIPTION | - DREBIN et al., Oncogene, (19880000), vol. 2, pages 273 - 277 | - |
| DESCRIPTION | - D'SOUZA et al., Proc. Natl. Acad. Sci., (19940000), vol. 91, pages 7202 - 7206 | - |
| DESCRIPTION | - EARP et al., Breast Cancer Research and Treatment, (19950000), vol. 35, pages 115 - 132 | - |
| DESCRIPTION | - EPSTEIN et al., Proc. Natl. Acad. Sci. USA, (19850000), vol. 82, page 3688 | - |
| DESCRIPTION | - FALLS et al., Cell, (19930000), vol. 72, pages 801 - 815 | - |
| DESCRIPTION | - FENDLY et al., Cancer Research, (19900000), vol. 50, pages 1550 - 1558 | - |
| DESCRIPTION | - FRANKLIN et al., Cancer Cell, (20040000), vol. 5, pages 317 - 328 | - |
| DESCRIPTION | - FUKUSHIGE et al., Mol Cell Biol., (19860000), vol. 6, pages 955 - 958 | - |
| DESCRIPTION | - GABIZON et al., J. National Cancer Inst., (19890000), vol. 81, no. 19, page 1484 | - |
| DESCRIPTION | - GARRETT et al., Mol. Cell, (20030000), vol. 11, pages 495 - 505 | - |
| DESCRIPTION | - GAZZANO-SANTORO et al., J. Immunol. Methods, (19960000), vol. 202, page 163 | - |
| DESCRIPTION | - "Genebank", Database accession no. X03363 | - |
| DESCRIPTION | - GODING, Monoclonal Antibodies: Principles and Practice, Academic Press, (19860000), pages 59 - 103 | - |
| DESCRIPTION | - GRIFFITH et al., EMBOJ., (19930000), vol. 12, pages 725 - 734 | - |
| DESCRIPTION | - GROENEN et al., Growth Factors, (19940000), vol. 11, pages 235 - 257 | - |
| DESCRIPTION | - GRUBER et al., J. Immunol., (19940000), vol. 152, page 5368 | - |
| DESCRIPTION | - GUERIN et al., Oncogene Res., (19880000), vol. 3, pages 21 - 31 | - |
| DESCRIPTION | - GU et al., Cancer Lett., (19960000), vol. 99, pages 185 - 9 | - |
| DESCRIPTION | - GUYER et al., J. Immunol., (19760000), vol. 117, page 587 | - |
| DESCRIPTION | - HANCOCK et al., Cancer Res., (19910000), vol. 51, pages 4575 - 4580 | - |
| DESCRIPTION | - HARARI et al., Oncogene, (19990000), vol. 18, pages 2681 - 89 | - |
| DESCRIPTION | - HARWERTH et al., J. Biol. Chem., (19920000), vol. 267, pages 15160 - 15167 | - |
| DESCRIPTION | - HIGASHIYAMA et al., Science, (19910000), vol. 251, pages 936 - 939 | - |
| DESCRIPTION | - HINMAN et al., Cancer Research, (19930000), vol. 53, pages 3336 - 3342 | - |
| DESCRIPTION | - HO et al., J. Biol. Chem., (19950000), vol. 270, pages 14523 - 14532 | - |
| DESCRIPTION | - HOLLINGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448 | - |
| DESCRIPTION | - HOLMES et al., Science, (19920000), vol. 256, pages 1205 - 1210 | - |
| DESCRIPTION | - HUDZIAK et al., Mol. Cell. Biol., (19890000), vol. 9, no. 3, pages 1165 - 1172 | - |
| DESCRIPTION | - HUMPHREY et al., PNAS (USA), (19900000), vol. 87, pages 4207 - 4211 | - |
| DESCRIPTION | - HWANG et al., Proc. Natl Acad. Sci. USA, (19800000), vol. 77, page 4030 | - |
| DESCRIPTION | - JAKOBOVITS et al., Nature, (19930000), vol. 362, pages 255 - 258 | - |
| DESCRIPTION | - JAKOBOVITS et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, page 2551 | - |
| DESCRIPTION | - JOHNS et al., J. Biol. Chem., (20040000), vol. 279, no. 29, pages 30375 - 30384 | - |
| DESCRIPTION | - JOHNSON, KEVIN S.; CHISWELL, DAVID J., Current Opinion in Structural Biology, (19930000), vol. 3, pages 564 - 571 | - |
| DESCRIPTION | - JONES et al., Nature, (19860000), vol. 321, pages 522 - 525 | - |
| DESCRIPTION | - KANNAN et al., J. Biol. Chem., (19970000), vol. 272, no. 6, pages 3330 - 3335 | - |
| DESCRIPTION | - KASPRZYK et al., Cancer Research, (19920000), vol. 52, pages 2771 - 2776 | - |
| DESCRIPTION | - KERN et al., Cancer Res., (19900000), vol. 50, page 5184 | - |
| DESCRIPTION | - KIM et al., J. Immunol., (19940000), vol. 24, page 249 | - |
| DESCRIPTION | - KIMURA et al., Nature, (19900000), vol. 348, pages 257 - 260 | - |
| DESCRIPTION | - KING et al., Science, (19850000), vol. 229, page 974 | - |
| DESCRIPTION | - KLAPPER et al., Oncogene, (19970000), vol. 14, pages 2099 - 2109 | - |
| DESCRIPTION | - KOHLER et al., Nature, (19750000), vol. 256, page 495 | - |
| DESCRIPTION | - KOMURASAKI et al., Oncogene, (19970000), vol. 15, pages 2841 - 2848 | - |
| DESCRIPTION | - KOSTELNY et al., J. Immunol., (19920000), vol. 148, no. 5, pages 1547 - 1553 | - |
| DESCRIPTION | - KOTTS et al., In Vitro, (19900000), vol. 26, no. 3, page 59A | - |
| DESCRIPTION | - KOZBOR, J. Immunol., (19840000), vol. 133, page 3001 | - |
| DESCRIPTION | - KRAUS et al., PNAS (USA), (19890000), vol. 86, pages 9193 - 9197 | - |
| DESCRIPTION | - KUMAR et al., Mol. Cell. Biol., (19910000), vol. 11, no. 2, pages 979 - 986 | - |
| DESCRIPTION | - LEE et al., Pharm. Rev., (19950000), vol. 47, pages 51 - 85 | - |
| DESCRIPTION | - LEMKE, G., Molec. & Cell. Neurosci., (19960000), vol. 7, pages 247 - 262 | - |
| DESCRIPTION | - LEVI et al., Journal of Neuroscience, (19950000), vol. 15, pages 1329 - 1340 | - |
| DESCRIPTION | - LEWIS et al., Cancer Immunol. Immunother., (19930000), vol. 37, pages 255 - 263 | - |
| DESCRIPTION | - LEWIS et al., Cancer Res., (19960000), vol. 56, pages 1457 - 1465 | - |
| DESCRIPTION | - LEWIS et al., Cancer Research, (19960000), vol. 56, pages 1457 - 1465 | - |
| DESCRIPTION | - LODE et al., Cancer Research, (19980000), vol. 58, pages 2925 - 2928 | - |
| DESCRIPTION | - MAIER et al., Cancer Res., (19910000), vol. 51, pages 5361 - 5369 | - |
| DESCRIPTION | - MARCHIONNI et al., Nature, (19930000), vol. 362, pages 312 - 318 | - |
| DESCRIPTION | - MARKS et al., BiolTechnology, (19920000), vol. 10, pages 779 - 783 | - |
| DESCRIPTION | - MARKS et al., J. Mol. Biol., (19910000), vol. 222, pages 581 - 597 | - |
| DESCRIPTION | - MARQUARDT et al., Science, (19840000), vol. 223, pages 1079 - 1082 | - |
| DESCRIPTION | - MARTIN et al., J. Biol. Chem., (19820000), vol. 257, pages 286 - 288 | - |
| DESCRIPTION | - MASUI et al., Cancer Research, (19840000), vol. 44, pages 1002 - 1007 | - |
| DESCRIPTION | - MCCAFFERTY et al., Nature, (19900000), vol. 348, pages 552 - 553 | - |
| DESCRIPTION | - MCCAFFERTY et al., Nature, (19900000), vol. 348, pages 552 - 554 | - |
| DESCRIPTION | - MCCANN et al., Cancer, (19900000), vol. 65, pages 88 - 92 | - |
| DESCRIPTION | - MCKENZIE et al., Oncogene, (19890000), vol. 4, pages 543 - 548 | - |
| DESCRIPTION | - MILLSTEIN et al., Nature, (19830000), vol. 305, pages 537 - 539 | - |
| DESCRIPTION | - MOLINA et al., Cancer Res., (20010000), vol. 61, pages 4744 - 4749 | - |
| DESCRIPTION | - MORIMOTO et al., Journal of Biochemical and Biophysical Methods, (19920000), vol. 24, pages 107 - 117 | - |
| DESCRIPTION | - MORRISON et al., Proc. Natl Acad. Sci. USA, (19840000), vol. 81, page 6851 | - |
| DESCRIPTION | - MORRISON et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6851 - 6855 | - |
| DESCRIPTION | - MORRISSEY et al., Proc. Natl. Acad. Sci. USA, (19950000), vol. 92, pages 1431 - 1435 | - |
| DESCRIPTION | - MUNSON et al., Anal. Biochem., (19800000), vol. 107, page 220 | - |
| DESCRIPTION | - MYERS et al., Meth. Enzym., (19910000), vol. 198, pages 277 - 290 | - |
| DESCRIPTION | - PARK et al., Cancer Res., (19890000), vol. 49, page 6605 | - |
| DESCRIPTION | - PELES et al., Cell, (19920000), vol. 69, pages 205 - 216 | - |
| DESCRIPTION | - PIETRAS et al., Oncogene, (19940000), vol. 9, pages 1829 - 1838 | - |
| DESCRIPTION | - PLOWMAN et al., Nature, (19930000), vol. 366, pages 473 - 475 | - |
| DESCRIPTION | - PLOWMAN et al., Proc. Natl. Acad. Sci., (19930000), vol. 90, pages 1746 - 1750 | - |
| DESCRIPTION | - PLOWMAN et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 1746 - 1750 | - |
| DESCRIPTION | - PLUCKTHUN, Immunol. Revs., (19920000), vol. 130, pages 151 - 188 | - |
| DESCRIPTION | - PLUCKTHUN, The Pharmacology of Monoclonal Antibodies, Springer-Verlag, (19940000), vol. 113, pages 269 - 315 | - |
| DESCRIPTION | - PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596 | - |
| DESCRIPTION | - PRESTA et al., J. Immunol., (19930000), vol. 151, page 2623 | - |
| DESCRIPTION | - RAVETCH; KINET, Annu. Rev. Immunol, (19910000), vol. 9, pages 457 - 92 | - |
| DESCRIPTION | - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327 | - |
| DESCRIPTION | - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 329 | - |
| DESCRIPTION | - ROSS et al., Cancer, (19970000), vol. 79, pages 2162 - 70 | - |
| DESCRIPTION | - ROSS et al., Hum. Pathol., (19970000), vol. 28, pages 827 - 33 | - |
| DESCRIPTION | - SADASIVAN et al., J. Urol., (19930000), vol. 150, pages 126 - 31 | - |
| DESCRIPTION | - SARUP et al., Growth Regulation, (19910000), vol. 1, pages 72 - 82 | - |
| DESCRIPTION | - SASADA et al., Biochem. Biophys. Res. Commun., (19930000), vol. 190, page 1173 | - |
| DESCRIPTION | - SAVAGE et al., J. Biol. Chem., (19720000), vol. 247, pages 7612 - 7621 | - |
| DESCRIPTION | - SCHAEFER et al., Oncogene, (19970000), vol. 15, pages 1385 - 1394 | - |
| DESCRIPTION | - SCOTT et al., J. Biol. Chem., (19910000), vol. 266, pages 14300 - 5 | - |
| DESCRIPTION | - SEMBA et al., PNAS (USA), (19850000), vol. 82, pages 6497 - 6501 | - |
| DESCRIPTION | - SHALABY et al., J. Exp. Med., (19920000), vol. 175, pages 217 - 225 | - |
| DESCRIPTION | - SHAWVER et al., Cancer Res., (19940000), vol. 54, pages 1367 - 1373 | - |
| DESCRIPTION | - SHEPARD et al., J. Clin. Immunol., (19910000), vol. 11, no. 3, pages 117 - 127 | - |
| DESCRIPTION | - SHING et al., Science, (19930000), vol. 259, pages 1604 - 1607 | - |
| DESCRIPTION | - SHOPES, B. J. Immunol., (19920000), vol. 148, pages 2918 - 2922 | - |
| DESCRIPTION | - SHOYAB et al., Science, (19890000), vol. 243, pages 1074 - 1076 | - |
| DESCRIPTION | - SIAS et al., J. Immunol. Methods, (19900000), vol. 132, pages 73 - 80 | - |
| DESCRIPTION | - SIMS et al., J. Immunol., (19930000), vol. 151, page 2296 | - |
| DESCRIPTION | - SKERRA et al., Curr. Opinion in Immunol., (19930000), vol. 5, pages 256 - 262 | - |
| DESCRIPTION | - SLAMON et al., Science, (19870000), vol. 235, pages 177 - 182 | - |
| DESCRIPTION | - SLAMON et al., Science, (19890000), vol. 244, pages 707 - 712 | - |
| DESCRIPTION | - SLIWKOWSKI et al., J. Biol. Chem., (19940000), vol. 269, no. 20, pages 14661 - 14665 | - |
| DESCRIPTION | - STANCOVSKI et al., PNAS (USA), (19910000), vol. 88, pages 8691 - 8695 | - |
| DESCRIPTION | - STEVENSON et al., Anti-Cancer Drug Design, (19890000), vol. 3, pages 219 - 230 | - |
| DESCRIPTION | - STRAGLIOTTO et al., Eur. J. Cancer, (19960000), vol. 32A, pages 636 - 640 | - |
| DESCRIPTION | - SURESH et al., Methods in Enzymology, (19860000), vol. 121, page 210 | - |
| DESCRIPTION | - TAGLIABUE et al., Int. J. Cancer, (19910000), vol. 47, pages 933 - 937 | - |
| DESCRIPTION | - TOYODA et al., J. Biol. Chem., (19950000), vol. 270, pages 7495 - 7500 | - |
| DESCRIPTION | - TRAUNECKER et al., EMBO J., (19910000), vol. 10, pages 3655 - 3659 | - |
| DESCRIPTION | - TUTT et al., J. Immunol., (19910000), vol. 147, page 60 | - |
| DESCRIPTION | - VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536 | - |
| DESCRIPTION | - VITETTA et al., Cancer Research, (19940000), vol. 54, pages 5301 - 5309 | - |
| DESCRIPTION | - VITETTA et al., Science, (19870000), vol. 238, page 1098 | - |
| DESCRIPTION | - WATERHOUSE et al., Nuc. Acids. Res., (19930000), vol. 21, pages 2265 - 2266 | - |
| DESCRIPTION | - WEINER et al., Cancer Res., (19900000), vol. 50, pages 421 - 425 | - |
| DESCRIPTION | - WILLIAMS et al., Pathobiology, (19910000), vol. 59, pages 46 - 52 | - |
| DESCRIPTION | - WOLFF et al., Cancer Research, (19930000), vol. 53, pages 2560 - 2565 | - |
| DESCRIPTION | - WU et al., J. Clin. Invest., (19950000), vol. 95, pages 1897 - 1905 | - |
| DESCRIPTION | - XU et al., Int. J. Cancer, (19930000), vol. 53, pages 401 - 408 | - |
| DESCRIPTION | - YAMAMOTO et al., Nature, (19860000), vol. 319, pages 230 - 234 | - |
| DESCRIPTION | - YOKOTA et al., Lancet, (19860000), vol. 1, pages 765 - 767 | - |
| DESCRIPTION | - YONEMURA et al., Cancer Res., (19910000), vol. 51, page 1034 | - |
| DESCRIPTION | - ZHANG et al., PNAS (USA, (19970000), vol. 94, no. 18, pages 9562 - 7 | - |
| DESCRIPTION | - ZHANG et al., Proc. Natl. Acad. Sci., (19970000), vol. 94, pages 9562 - 9567 | - |
| DESCRIPTION | - ZHAU et al., Mol. Carcinog., (19900000), vol. 3, pages 254 - 257 | - |
| OPPOSITION | - Anonymous, "CMC Forum: Standard Reference Materials for Biopharmaceutical Products", The Gold Sheet, (20060601), vol. 40, no. 6, pages 1 - 20, XP055775788 | - |
| OPPOSITION | - Anonymous, "Glycation", Wikipedia, the free encyclopedia, (20071206), Wikipedia, the free encyclopedia, URL: https://en.wikipedia.org/w/index.php?title=Glycation&oldid=176148941, (20210215), XP055775783 | - |
| OPPOSITION | - Anonymous, "ICH Topic Q 6 B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products ", EMEA European Medicines Agency, (19990901), pages 1 - 17, EMEA European Medicines Agency, URL: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-6-b-test-procedures-acceptance-criteria-biotechnological/biological-products-step-5_en.pdf, (20220404), XP055908691 | - |
| OPPOSITION | - Chowdhury Swapan K, Et Al, "Origin and removal of adducts (molecular mass = 98 u) attached to peptide and protein ions in electrospray ionization mass spectra", J Am Soc Mass Spectrom, (19900101), vol. 1, pages 382 - 388, XP055912422 | - |
| OPPOSITION | - Emea, "ICH Topic Q 5 E Comparability of Biotechnological/Biological Products", European Medicines Agency, (20050601), pages 1 - 13, XP055912425 | - |
| OPPOSITION | - Fda, "Guidance for Industry INDs for Phase 2 and 3 Studies of Drugs, Including Specified Therapeutic Biotechnology-Derived Products Chemistry, Manufacturing, and Controls Content and Format", FDA - Draft Guidance, (19990201), FDA - Draft Guidance, URL: http://www.msk.nclinnovations.org/medregulations/v1/html/Guidance/Guidance_IND%20Content%20Phase%20II%20&%20III.pdf, (20210215), XP055775791 | - |
| OPPOSITION | - GIBCO BRL, "A Guide to Serum-Free Cell Culture", INVITROGEN CATALOGUE, XX, XX, XX , (20030101), pages 1 - 11, XP003001930 | - |
| OPPOSITION | - HARRIS, "Heterogeneity of recombinant antibodies: linking structure to function", Develop Biol, (20050000), vol. 122, pages 117 - 127, XP008090894 | - |
| OPPOSITION | - HARRIS, R.J., "Heterogeneity of Recombinant Antibodies: Linking structure to function", Dev. Biol., Basel, (20050000), vol. 122, pages 117 - 127, XP008090894 | - |
| OPPOSITION | - Harris R J, "Heterogeneity of recombinant antibodies: linking structure to function", DEVELOPMENTS IN BIOLOGICALS, CH , (20050101), vol. 122, ISSN 1424-6074, pages 117 - 127, XP008090894 | - |
| OPPOSITION | - Harris R J, "Heterogeneity of recombinant antibodies: linking structure to function.", DEVELOPMENTS IN BIOLOGICALS, CH , (20050101), vol. 122, ISSN 1424-6074, pages 117 - 127, XP008090894 | - |
| OPPOSITION | - Ion Exchange Chromatography & Chromatofocusing - Principles and Methods, Amersham Biosciences, (20040101), XP055982380 | - |
| OPPOSITION | - Motchnik Paul et al, "P-219-W Acidic variants of monoclonal antibodies: Origins, characteristics and impact on pharmacokinetics", Abstract, (20080101), pages 110 - 111, Abstract, (20210215), XP055775802 | - |
| OPPOSITION | - Ozturk S S, Hu Wei-Shou (eds.), "Cell Culture Technology for Pharmaceutical and Cell-Based Therapies", (20060101), pages 41 - 79, XP055912400 | - |
| OPPOSITION | - ROBINSON, N.E. et al., "Prediction of primary structure deamidation rates of asparaginyl and glutaminyl peptides through steric and catalytic effects", J Peptide Res, (20040000), vol. 63, pages 437 - 448, XP055912437 | - |
| OPPOSITION | - "Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products", ICH Topic Q 6 B, (19990901), XP055775816 | - |
| OPPOSITION | - Wei Bingchuan, Et Al, "Glycation of antibodies: Modification, methods and potential effects on biological functions", MABS, (20170101), vol. 9, no. 4, pages 586 - 594, XP055912445 | - |
| OPPOSITION | - Yuk et al., "Controlling glycation of recombinant antibody in fed-batch cell cultures", Biotechnol Bioeng, (20111100), vol. 108, no. 11, doi:10.1002/bit.23218, pages 2600 - 2610, XP055171183 | |
| OPPOSITION | - L. C. Santora et al, "Characterization of maleuric acid derivatives on transgenic human monoclonal antibody due to post-secretional modifications in goat milk", Biomedical Chromatography, (20060901), vol. 20, no. 9, doi:10.1002/bmc.603, ISSN 02693879, pages 843 - 856, XP055169390 | |
| OPPOSITION | - HARRIS et al., "Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies", Drug Dev Res, (20040000), vol. 61, doi:10.1002/ddr.10344, pages 137 - 154, XP002649544 | |
| OPPOSITION | - HARRIS R J, SHIRE S J, WINTER C, "Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies", DRUG DEVELOPMENT RESEARCH, US , (20040301), vol. 61, no. 3, doi:10.1002/ddr.10344, ISSN 0272-4391, pages 137 - 154, XP002324970 | |
| OPPOSITION | - WANG et al., "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", Journal of Pharmaceutical Sciences, US , (20070101), vol. 96, no. 1, doi:10.1002/jps.20727, ISSN 0022-3549, pages 1 - 26, XP009084505 | |
| OPPOSITION | - WANG et al., "Antibody structure, instability, and formulation", J Pharmaceutical Sci, vol. 96, no. 1, doi:10.1002/jps.20727, (20070000), pages 1 - 26, XP009084505 | |
| OPPOSITION | - WANG W; SINGH S; ZENG D L; KING K; NEMA S, "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", Journal of Pharmaceutical Sciences, American Chemical Society and American Pharmaceutical Association, US, US , (20070101), vol. 96, no. 1, doi:10.1002/jps.20727, ISSN 0022-3549, pages 1 - 26, XP009084505 | |
| OPPOSITION | - WANG W; SINGH S; ZENG D L; KING K; NEMA S, "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", Journal of Pharmaceutical Sciences, US , (20070101), vol. 96, no. 1, doi:10.1002/jps.20727, ISSN 0022-3549, pages 1 - 26, XP009084505 | |
| OPPOSITION | - Hongcheng Liu, Georgeen Haza-Bulseco, Dinesh Faldu, Chris Chumsae And Joanne Sun, "Heterogeneity of Monoclonal Antibodies", Journal of Pharmaceutical Sciences, (20080701), vol. 97, no. 7, doi:10.1002 /jps.21180, pages 2426 - 2447, XP055551051 | |
| OPPOSITION | - Liu et al., "Heterogeneity of Monoclonal Antibodies", Journal of Pharmaceutical Sciences, (20080701), vol. 97, no. 7, doi:10.1002 /jps.21180, pages 2426 - 2447, XP055551051 | |
| OPPOSITION | - LIU et al., "Heterogeneity of monoclonal antibodies", J Pharmaceutical Sci, (20070000), vol. 97, no. 7, pages 2426 - 2447, XP055551051 | |
| OPPOSITION | - LIU H. et al., "Heterogeneity of Monoclonal Antibodies", Journal of Pharmaceutical Sciences, (20080700), vol. 97, no. 7, XP055551051 | |
| OPPOSITION | - SANTORA L C et al, "Characterization of recombinant human monoclonal tissue necrosis factor-alpha antibody using cation-exchange HPLC and capillary isoelectric focusing", Analytical Biochemistry, Amsterdam, NL , (19991101), vol. 275, no. 1, doi:10.1006/abio.1999.4275, ISSN 0003-2697, pages 98 - 108, XP002433060 | |
| OPPOSITION | - RAO et al., "Orthoclone OKT3 - Chemical mechanisms and functional effects of degradation of a therapeutic monoclonal antibody", Stability and Characterization of Protein and Peptide Drugs: Case Histories, (19930000), vol. 4, doi:10.1007/978-1-4899-1236-7_4, pages 135 - 158, XP055551359 | |
| OPPOSITION | - MA et al., "Analysis of protein therapeutics by capillary electrophoresis", Chromatographia, (20010000), pages S-75 - S-89, XP055908674 | |
| OPPOSITION | - Ma et al., "Analysis of Protein Therapeutics by Capillary Electrophoresis", Chromatographia Suppl., (20010101), vol. 53, pages 75 - 89, XP055908674 | |
| OPPOSITION | - Ma S., Nashabeh W., "Analysis of Protein Therapeutics by Capillary Electrophoresis", CE in Biotechnology: Practical Applications for Protein and Peptide Analyses, Wiesbaden, Vieweg+Teubner Verlag, (20010101), vol. 5, pages 75 - 89, doi:10.1007/978-3-322-83021-0_9, ISSN 1615-2255, ISBN 978-3-322-83021-0, XP055908674 | |
| OPPOSITION | - Hendrik Emons ; Ales Fajgelj ; Adriaan M. H. van der Veen ; Robert Watters, "New definitions on reference materials", Accreditation and Quality Assurance ; Journal for Quality, Comparability and Reliability in Chemical Measurement, Springer, Berlin, DE, Berlin, DE , (20060201), vol. 10, no. 10, doi:10.1007/s00769-006-0089-9, ISSN 1432-0517, pages 576 - 578, XP019351417 | |
| OPPOSITION | - Hongcheng Liu ; Georgeen Gaza-Bulseco ; Chris Chumsae ; Abigail Newby-Kew, "Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE", Biotechnology Letters, Springer Netherlands, Dordrecht, Dordrecht , (20070704), vol. 29, no. 11, doi:10.1007/s10529-007-9449-8, ISSN 1573-6776, pages 1611 - 1622, XP019523988 | |
| OPPOSITION | - LIU et al., "Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE", Biotechnol Lett, (20070000), vol. 29, doi:10.1007/s10529-007-9449-8, pages 1611 - 1622, XP019523988 | |
| OPPOSITION | - WEINBERG et al., "Development and regulation of monoclonal antibody products: Challenges and opportunities", Cancer Metastasis Rev, (20050000), vol. 24, doi:10.1007/s10555-005-6196-y, pages 569 - 584, XP019205206 | |
| OPPOSITION | - Virella, G. ; Parkhouse, R.M.E., "Sensitivity to reduction of human immunoglobulin G of different heavy chain sub-classes", Immunochemistry, Pergamon, GB, GB , (19730401), vol. 10, no. 4, doi:10.1016/0019-2791(73)90197-3, ISSN 0019-2791, pages 213 - 217, XP023935752 | |
| OPPOSITION | - HUNT et al., "Capillary isoelectric focusing and sodium dodecyl sulfate capillary gel electrophoresis of recombinant humanized monoclonal antibody HER2", J Chromatog A, (19960000), vol. 744, doi:10.1016/0021-9673(96)00437-2, pages 295 - 301, XP004020331 | |
| OPPOSITION | - Quan, C. Alcala, E. Petkovska, I. Matthews, D. Canova-Davis, E. Taticek, R. Ma, S., "A study in glycation of a therapeutic recombinant humanized monoclonal antibody: Where it is, how it got there, and how it affects charge-based behavior", Analytical Biochemistry, Academic Press, Amsterdam, NL, Amsterdam, NL , (20080105), vol. 373, no. 2, doi:10.1016/j.ab.2007.09.027, ISSN 0003-2697, pages 179 - 191, XP022411097 | |
| OPPOSITION | - Quan, C. Alcala, E. Petkovska, I. Matthews, D. Canova-Davis, E. Taticek, R. Ma, S., "A study in glycation of a therapeutic recombinant humanized monoclonal antibody: Where it is, how it got there, and how it affects charge-based behavior", Analytical Biochemistry, Amsterdam, NL , (20080105), vol. 373, no. 2, doi:10.1016/j.ab.2007.09.027, ISSN 0003-2697, pages 179 - 191, XP022411097 | |
| OPPOSITION | - QUAN et al., "A study in glycation of a therapeutic recombinant humanized monoclonal antibody: Where it is, how it got there, and how it affects charge-based behavior", Anal Biochem, vol. 373, doi:10.1016/j.ab.2007.09.027, (20070000), pages 179 - 191, XP022411097 | |
| OPPOSITION | - Quan et al., "A study in glycation of a therapeutic recombinant humanized monoclonal antibody: Where it is, how it got there, and how it affects charge-based behavior", Analytical Biochemistry, Amsterdam, NL , (20080105), vol. 373, no. 2, doi:10.1016/j.ab.2007.09.027, ISSN 0003-2697, pages 179 - 191, XP022411097 | |
| OPPOSITION | - RIDDLES et al., "Reassessment of Ellman's reagent", Meth Enzymol, (19830000), vol. 91, doi:10.1016/S0076-6879(83)91010-8, pages 49 - 60, XP055551047 | |
| OPPOSITION | - RIDDLES P.W. et al., "Reassessment of Ellman's Reagent", Methods in Enzymology, (19830000), vol. 91, doi:10.1016/S0076-6879(83)91010-8, pages 49 - 60, XP055551047 | |
| OPPOSITION | - Oscar Salas-Solano, Chantal Felten, "15 Capillary electrophoresis and bioanalysis", Capillary electrophoresis methods for pharmaceutical analysis, doi:10.1016/S0149-6395(07)00015-3, ISBN 978-0-12-372573-8, (20080101), pages 401 - 424, Capillary electrophoresis methods for pharmaceutical analysis, (20190204), XP055551375 | |
| OPPOSITION | - Oscar Salas-Solano, Chantal Felten, "15 Capillary electrophoresis and bioanalysis", Capillary electrophoresis methods for pharmaceutical analysis, Elsevier, doi:10.1016/S0149-6395(07)00015-3, ISBN 978-0-12-372573-8, (20080101), pages 401 - 424, Capillary electrophoresis methods for pharmaceutical analysis, (20190204), XP055551375 | |
| OPPOSITION | - Salas-Solano et al., "15 Capillary electrophoresis and bioanalysis", Salas-Solano et al., Ahuja et al., Capillary electrophoresis methods for pharmaceutical analysis, (20080101), pages 401 - 424, doi:10.1016/S0149-6395(07)00015-3, ISBN 978-0-12-372573-8, XP055551375 | |
| OPPOSITION | - SALAS-SOLANO et al., "Capillary electrophoresis and bioanalysis", Capillary electrophoresis methods for pharmaceutical analysis, (20080726), vol. 15, doi:10.1016/S0149-6395(07)00015-3, pages 401 - 424, XP055551375 | |
| OPPOSITION | - HARRIS et al., "Identification of multiple sources of charge heterogeneity in a recombinant antibody", J Chromatography B, (20010000), vol. 752, doi:10.1016/S0378-4347(00)00548-X, pages 233 - 245, XP004317158 | |
| OPPOSITION | - Guillermo I. Tous, Ziping Wei, Jinhua Feng, Susanna Bilbulian, Stephen Bowen, Jaime Smith, Robert Strouse, Patrick Mcgeehan, Jose Casas-Finet, Mark A. Schenerman, "Characterization of a Novel Modification to Monoclonal Antibodies:Â Thioether Cross-link of Heavy and Light Chains", Analytical Chemistry, American Chemical Society, US, US , (20050501), vol. 77, no. 9, doi:10.1021/ac0500582, ISSN 0003-2700, pages 2675 - 2682, XP055551114 | |
| OPPOSITION | - Guillermo I. Tous, Ziping Wei, Jinhua Feng, Susanna Bilbulian, Stephen Bowen, Jaime Smith, Robert Strouse, Patrick Mcgeehan, Jose Casas-Finet, Mark A. Schenerman, "Characterization of a Novel Modification to Monoclonal Antibodies:Â Thioether Cross-link of Heavy and Light Chains", Analytical Chemistry, US , (20050501), vol. 77, no. 9, doi:10.1021/ac0500582, ISSN 0003-2700, pages 2675 - 2682, XP055551114 | |
| OPPOSITION | - TOUS et al., "Characterization of a novel modification to monoclonal antibodies: Thioether cross-link of heavy and light chains", Anal Chem, (20050000), vol. 77, no. 9, doi:10.1021/ac0500582, pages 2675 - 2682, XP055551114 | |
| OPPOSITION | - Tous et al., "Characterization of a Novel Modification to Monoclonal Antibodies: Thioether Cross-link of Heavy and Light Chains", Analytical Chemistry, US , (20050501), vol. 77, no. 9, doi:10.1021/ac0500582, ISSN 0003-2700, pages 2675 - 2682, XP055551114 | |
| OPPOSITION | - SALAS-SOLANO et al., "Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies", Anal Chem, (20060000), vol. 78, no. 18, pages 6583 - 6594, XP002519390 | |
| OPPOSITION | - SALAS-SOLANO et al., "Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies.", Analytical Chemistry, US , (20060915), vol. 78, no. 18, doi:10.1021/AC060828P, ISSN 0003-2700, pages 6583 - 6594, XP002519390 | |
| OPPOSITION | - SALAS-SOLANO OSCAR ET AL, "Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies.", Analytical Chemistry, US , (20060915), vol. 78, no. 18, doi:10.1021/AC060828P, ISSN 0003-2700, pages 6583 - 6594, XP002519390 | |
| OPPOSITION | - ZHANG et al., "Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody", Anal Chem, (20080000), vol. 80, doi:10.1021/ac701810q, pages 2379 - 2390, XP002478266 | |
| OPPOSITION | - HUNT et al., "Capillary electrophoresis sodium dodecyl sulfate nongel sieving analysis of a therapeutic recombinant monoclonal antibody: A biotechnology perspective", Anal Chem, (19990000), vol. 71, no. 13, doi:10.1021/ac981209m, pages 2390 - 2397, XP055534370 | |
| OPPOSITION | - Hunt et al., "Capillary electrophoresis sodium dodecyl sulfate nongel sieving analysis of a therapeutic recombinant monoclonal antibody: a biotechnology perspective", Anal Chem., (19990101), vol. 71, no. 13, doi:10.1021/ac981209m, pages 2390 - 2397, XP055534370 | |
| OPPOSITION | - Hunt, Et Al, "Capillary electrophoresis sodium dodecyl sulfate nongel sieving analysis of a therapeutic recombinant monoclonal antibody: a biotechnology perspective", Anal Chem., (19990101), vol. 71, no. 13, doi:10.1021/ac981209m, pages 2390 - 2397, XP055534370 | |
| OPPOSITION | - ZHANG et al., "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnology Progress, (20020501), vol. 18, no. 3, doi:10.1021/BP025511Z, ISSN 8756-7938, pages 509 - 513, XP002500112 | |
| OPPOSITION | - ZHANG et al., "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnol. Prog., (20020000), vol. 18, no. 3, doi:10.1021/BP025511Z, pages 509 - 513, XP002500112 | |
| OPPOSITION | - ZHANG WEI, CZUPRYN M J, "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnology Progress, (20020501), vol. 18, no. 3, doi:10.1021/BP025511Z, ISSN 8756-7938, pages 509 - 513, XP002500112 | |
| OPPOSITION | - ZHANG WEI, CZUPRYN M J, "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnology Progress, American Chemical Society, (20020501), vol. 18, no. 3, doi:10.1021/BP025511Z, ISSN 8756-7938, pages 509 - 513, XP002500112 | |
| OPPOSITION | - ZHANG W. et al., "Free Sulfhydryl in Recombinant Monoclonal Antibodies", Biotechnol. Prag., (20021104), vol. 18, doi:10.1021/BP025511Z, pages 509 - 513, XP002500112 | |
| OPPOSITION | - CHADERJIAN et al., "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", Biotechnol Prog, (20050000), vol. 21, no. 2, pages 550 - 553, XP009107034 | |
| OPPOSITION | - CHADERJIAN W.B. et al., "Effect of Copper Sulfate on Performance of a serum-free CHO cell culture process and the level of Free Thiol in the recombinant Antibody expressed", Biotechnol. Progr., vol. 21, (20050000), pages 550 - 553, XP009107034 | |
| OPPOSITION | - Catak et al., "Reaction Mechanism of Deamidation of Asparaginyl Residues in Peptides: Effect of Solvent Molecules", The Journal of Physical Chemistry A, US , (20060701), vol. 110, no. 27, doi:10.1021/jp056991q, ISSN 1089-5639, pages 8354 - 8365, XP055775790 | |
| OPPOSITION | - Catak Saron et al, "Reaction Mechanism of Deamidation of Asparaginyl Residues in Peptides: Effect of Solvent Molecules †", The Journal of Physical Chemistry, US , (20060701), vol. 110, no. 27, doi:10.1021/jp056991q, ISSN 1089-5639, pages 8354 - 8365, XP055775790 | |
| OPPOSITION | - Catak Saron, Monard Gérald, Aviyente Viktorya, Ruiz-López Manuel F., "Reaction Mechanism of Deamidation of Asparaginyl Residues in Peptides: Effect of Solvent Molecules †", The Journal of Physical Chemistry A, Washington DC, US, US , (20060701), vol. 110, no. 27, doi:10.1021/jp056991q, ISSN 1089-5639, pages 8354 - 8365, XP055775790 | |
| OPPOSITION | - KROON et al., "Identification of sites of degradation in a therapeutic monoclonal antibody by peptide mapping", Pharmac Res, (19920000), vol. 9, no. 11, doi:10.1023/A:1015894409623, pages 1386 - 1393, XP002079908 | |
| OPPOSITION | - JENKINS et al., "Getting the glycosylation right: Implications for the biotechnology industry", Nat Biotechnol, (19960000), vol. 14, doi:10.1038/nbt0896-975, pages 975 - 981, XP002133654 | |
| OPPOSITION | - JENKINS et al., "Getting the glycosylation right: implications for the biotechnology industry", Nature Biotechnology, New York, (19960801), vol. 14, no. 8, doi:10.1038/nbt0896-975, ISSN 1087-0156, pages 975 - 981, XP002133654 | |
| OPPOSITION | - JENKINS N. ET AL., "Getting the glycosylation right: implications for the biotechnology dustry.", Nature Biotechnology, New York, (19960801), vol. 14., no. 08., doi:10.1038/nbt0896-975, ISSN 1087-0156, pages 975 - 981., XP002133654 | |
| OPPOSITION | - JENKINS N. ET AL., "Getting the glycosylation right: implications for the biotechnology industry.", Nature Biotechnology, Nature Publishing Group US, New York, New York, (19960801), vol. 14., no. 08., doi:10.1038/nbt0896-975, ISSN 1087-0156, pages 975 - 981., XP002133654 | |
| OPPOSITION | - WURM, "Production of recombinant protein therapeutics in cultivated mammalian cells", Nat Biotechnol, (20040000), vol. 22, no. 11, pages 1393 - 1398, XP002514352 | |
| OPPOSITION | - FAHRNER et al., "Industrial purification of pharmaceutical antibodies: Development, operation, and validation of chromatography processes", Biotechnol Genetic Eng Rev, (20010000), vol. 18, doi:10.1080/02648725.2001.10648017, pages 301 - 327, XP008034714 | |
| OPPOSITION | - AGUS et al., "Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer", J Clin Oncol, (20050000), vol. 23, no. 11, doi:10.1200/JCO.2005.03.184, pages 2534 - 2543, XP008058275 | |
| OPPOSITION | - BASELGA et al., "Objective response rate in a phase II multicenter trial of pertuzumab (P), a HER2 dimerization inhibiting monoclonal antibody, in combination with trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC) which has progressed during treatment with T", J Clin Oncol, (20070000), vol. 25, no. 8, page 1004, XP002778678 | |
| OPPOSITION | - Vlasak et al., "Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, NL , (20081201), vol. 9, no. 6, doi:10.2174/138920108786786402, ISSN 1389-2010, pages 468 - 481, XP008116104 | |
| OPPOSITION | - VLASAK et al., "Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods", Curr Pharmac Biotechnol, (20080000), vol. 9, doi:10.2174/138920108786786402, pages 468 - 481, XP008116104 | |
| OPPOSITION | - Vlasak J; Ionescu R, "Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, BENTHAM SCIENCE PUBLISHERS,, NL, NL , (20081201), vol. 9, no. 6, doi:10.2174/138920108786786402, ISSN 1389-2010, pages 468 - 481, XP008116104 | |
| OPPOSITION | - Vlasak J; Ionescu R, "Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, NL , (20081201), vol. 9, no. 6, doi:10.2174/138920108786786402, ISSN 1389-2010, pages 468 - 481, XP008116104 | |
| OPPOSITION | - KHAWLI et al., "Charge variants in IgG1", MAbs, (20100000), vol. 2, no. 6, doi:10.4161/mabs.2.6.13333, pages 613 - 624, XP055366646 | |
| OPPOSITION | - Leslie A. Khawli, Sirj Goswami, Ryan Hutchinson, Zephania W. Kwong, Jihong Yang, Xiangdan Wang, Zhenling Yao, Alavattam Sreedhara, Tony Cano, Devin B. Tesar, Ihsan Nijem, David E. Allison, Pin Yee Wong, Yung-Hsiang Kao, Cynthia Quan, Amita Joshi, Reed J. Harris, Paul Motchnik, "Charge variants in IgG1", mAbs, Landes Bioscience, US, US , (20101101), vol. 2, no. 6, doi:10.4161/mabs.2.6.13333, ISSN 1942-0862, pages 613 - 624, XP055366646 | |
| OPPOSITION | - LIU et al., "Disulfide bond structures of IgG molecules - structural variations, chemical modifications and possible impacts to stability and biological function", mAbs, vol. 4, no. 1, doi:10.4161/mabs.4.1.18347, pages 17 - 23, XP055696189 | |
| OPPOSITION | - R W Seward, "NBS standard reference materials catalog 1988-89 NBS SP 260e1988", (19880101), Database accession no. NBS SP 260e1988, XP061046830 | |
| SEARCH | - HARRIS R J, "Heterogeneity of recombinant antibodies: linking structure to function", DEVELOPMENTS IN BIOLOGI, KARGER, BASEL, CH, (20050101), vol. 122, ISSN 1424-6074, pages 117 - 127, XP008090894 [A] 1-9 * the whole document * | - |
| SEARCH | - WANG W ET AL, "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, US, (20070101), vol. 96, no. 1, doi:10.1002/JPS.20727, ISSN 0022-3549, pages 1 - 26, XP009084505 [A] 1-9 * the whole document * | |
| SEARCH | - H. LIU ET AL., "Heterogeneity of monoclonal antibodies.", JOURNAL OF PHARMACEUTICAL SCIENCES, USA, (200807), vol. 97, no. 7, pages 2426 - 2447, XP002530921 [PA] 1-9 * abstract * * sections 'disulfide bonds', 'C-terminal lysine processing', 'deamidation', 'oxidation' and 'glycation' * | |
| SEARCH | - R. HARRIS ET AL., "Identification of multiple sources of charge heterogeneity in a recombinant antibody.", JOURNAL OF CHROMATOGRAPHY. B, BIOMEDICAL SCIENCES AND APPLICATIONS, The Netherlands, (20010310), vol. 752, no. 2, pages 233 - 245, XP004317158 [A] 1-9 * abstract * | |
| SEARCH | - GUILLERMO I. TOUS ET AL, "Characterization of a Novel Modification to Monoclonal Antibodies:? Thioether Cross-link of Heavy and Light Chains", ANALYTICAL CHEMISTRY, (20050501), vol. 77, no. 9, doi:10.1021/ac0500582, ISSN 0003-2700, pages 2675 - 2682, XP055189954 [A] 1-9 * the whole document * | |
| SEARCH | - ZHANG WEI ET AL, "Free sulfhydryl in recombinant monoclonal antibodies", BIOTECHNOLOGY PROGRESS, AMERICAN INSTITUTE OF CHEMICAL ENGINEERS, US, (20020501), vol. 18, no. 3, doi:10.1021/BP025511Z, ISSN 8756-7938, pages 509 - 513, XP002500112 [A] 1-9 * the whole document * | |
| SEARCH | - M. PERKINS ET AL., "Determination of the origin of charge heterogeneity in a murine monoclonal antibody.", PHARMACEUTICAL RESEARCH, USA, (200009), vol. 17, no. 9, pages 1110 - 1117, XP002479461 [A] 1-9 * the whole document * | |
| SEARCH | - D. AGUS ET AL., "Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer.", JOURNAL OF CLINICAL ONCOLOGY, USA, (20050410), vol. 23, no. 11, pages 2534 - 2543, XP008058275 [A] 1-9 * abstract * | |
